]>
IRCT20200707048045N1 IRCT 2020-09-03 Shiraz University of Medical Sciences Vital sign changes in use of prilocaine and mepivacaine Hemodynamic changes (heart rate, blood pressure and oxygen saturation) comparing mepivacaine Hcl 3% with perilocaine 3%+ felypressin in controlled hypertensive patients after infra-alveolar block. 2020-06-22 anticipated 32 Complete https://irct.ir/trial/49507 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The drugs are coded into two groups A and B by the assistant and then the table of random numbers is used as code A of even numbers and code B of odd numbers, Blinding description: The drugs are coded by the assistant without the researcher's knowledge and the patient is aware of participating in the study but does not know which of the two drugs is used. 2-3 controlled hypertensive patients. Intervention 1: Intervention group: 16 patients with injection of perilocain 3%+ felypressin daru pakhsh. Intervention 2: Intervention group: 16 patients with mepivacain hydrochlorid 3% eksir. Yes - There is a plan to make this available What will be shared: Questionnaire, consent form, and data form When: Access period starts 6 months after printing To whom: Researchers working in academic and scientific institutions Conditions: Researchers who are certified by academic and scientific institutions. Where to obtain: Shiraz School of Dentistry How to obtain: Contact Shiraz Dental School Research Unit Comments:
public Ahmad Homayoun
111 NO,7th alley,Abrishami St
Shiraz Iran (Islamic Republic of) 7147768518 +98 71 3228 4031 ahmad.homayoun9@gmail.com Shiraz University of Medical Sciences scientific Ahmad Homayoun
111 NO,7th alley,Abrishami St
Shiraz Iran (Islamic Republic of) 7147768518 +98 71 3228 4031 Ahmad.homayoun9@gmail.com Shiraz University of Medical Sciences Iran (Islamic Republic of) Patients with controlled hypertension who are willing to cooperate 30 years 80 years Both Patients with a history of drug allergy, a history of asthma, nasal polyps, bronchospasm or angioedema, heart failure or liver failure, pregnancy, patients with idiopathic or congenital methemoglobinemia, patients with bleeding disorders, patients taking anticoagulant drugs failure to sign a written consent Treatment - Drugs Treatment - Drugs Intervention group: 16 patients with injection of perilocain 3%+ felypressin daru pakhsh Intervention group: 16 patients with mepivacain hydrochlorid 3% eksir Heart rate. Timepoint: Before intervention and 10 , 30 minute after. Method of measurement: Pulse oximeter. Blood pressure. Timepoint: Before intervention and 10 , 30 minute after. Method of measurement: Blood pressure monitor. Blood oxygen saturation. Timepoint: Before intervention and 10 , 30 minute after. Method of measurement: Pulse oximeter. Stress score. Timepoint: before and after intervention. Method of measurement: questionnaire. Shiraz University of Medical Sciences Approved 2020-06-21 Ethics committee of Shiraz University of Medical Sciences No 111, 7th Abrishami Alley Shiraz Fars Iran (Islamic Republic of)